A new study published in Chinese Medical Journal points to two new possible contributors to non-alcoholic fatty liver disease (NAFLD) — bile acids and lipid metabolism dysregulation. Typically associated with obesity, insulin resistance, and type 2 diabetes, NAFLD is characterized as a metabolic disease. NAFLD can progress into Nonalcoholic steatohepatitisRead
Recognizing the contribution and inter-relatedness of lipoprotein risk factors is critical to prioritizing treatment strategies for cardiovascular risk reduction. Lipoprotein factors still dominate risk for developing cardiovascular disease, including myocardial infarction. Some emerging risk factors such as C-reactive protein…
Weekly round-up, access to thought leaders, and articles to help you improve health outcomes and the success of your practice.
